Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Current Cardiology Reports"
DOI: 10.1007/s11886-021-01627-8
Abstract: Purpose of Review The role of monotherapy with a P2Y12 inhibitor for secondary prevention of cardiovascular diseases has been assessed in several randomized trials. In this article, we summarize the evidence regarding P2Y12 monotherapy for… read more here.
Keywords: role monotherapy; monotherapy p2y12; secondary prevention; monotherapy ... See more keywords